Joseph Baroldi is EVP, Chief Business Officer of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 19,631 shares of IONS, which is worth approximately $737,536. The most recent transaction as insider was on Apr 16, 2024, when has been sold 4,006 shares (Common Stock) at a price of $41.6 per share, resulting in proceeds of $166,649. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.6K
53.38% 3M change
85.71% 12M change
Total Value Held $737,536

Joseph Baroldi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 16 2024
SELL
Open market or private sale
$166,649 $41.6 p/Share
4,006 Reduced 16.95%
19,631 Common Stock
Apr 15 2024
BUY
Exercise of conversion of derivative security
-
10,838 Added 31.44%
23,637 Common Stock
Jan 17 2024
SELL
Open market or private sale
$73,613 $50.42 p/Share
1,460 Reduced 10.24%
12,799 Common Stock
Jan 16 2024
BUY
Exercise of conversion of derivative security
-
3,688 Added 20.55%
14,259 Common Stock
Apr 18 2023
SELL
Open market or private sale
$141,620 $36.5 p/Share
3,880 Reduced 26.85%
10,571 Common Stock
Apr 17 2023
BUY
Exercise of conversion of derivative security
-
10,838 Added 42.86%
14,451 Common Stock

Also insider at

RNA
Avidity Biosciences, Inc. Healthcare
JB

Joseph Baroldi

EVP, Chief Business Officer
Carlsbad, CA

Track Institutional and Insider Activities on IONS

Follow IONIS PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IONS shares.

Notify only if

Insider Trading

Get notified when an Ionis Pharmaceuticals Inc insider buys or sells IONS shares.

Notify only if

News

Receive news related to IONIS PHARMACEUTICALS INC

Track Activities on IONS